Clarus director granted 20,000 stock options

Clarus Corp director Susan Ottmann received a grant of stock options covering 20,000 shares of common stock.

Rhea-AI Filing Summary

Clarus Corp director Susan Ottmann received a grant of stock options covering 20,000 shares of common stock. These options have an exercise price of $3.11 per share and expire on May 28, 2036. The grant was made under the company’s Amended and Restated 2015 Stock Incentive Plan.

The options vest in four equal installments of 5,000 shares each, becoming exercisable on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Ottmann holds 20,000 stock options directly.

Insider Trade Summary

Grant/Award: 20,000 shares

Grant/Award 1 txn

Insider Ottmann Susan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to purchase)	20,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to purchase) — 20,000 contracts (Direct)

Footnotes (1)

1. F1. The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

Key Figures

Option grant size: 20,000 options Exercise price: $3.11 per share Expiration date: May 28, 2036 +5 more

8 metrics

Option grant size 20,000 options Stock Option (right to purchase) granted May 28, 2026

Exercise price $3.11 per share Conversion or exercise price of options

Expiration date May 28, 2036 Option expiration date

Post-transaction options held 20,000 options Total derivative securities owned after grant

First vesting tranche 5,000 options Vest on June 30, 2026

Second vesting tranche 5,000 options Vest on September 30, 2026

Third vesting tranche 5,000 options Vest on December 31, 2026

Fourth vesting tranche 5,000 options Vest on March 31, 2027

Key Terms

Stock Option (right to purchase), Amended and Restated 2015 Stock Incentive Plan, vest and become exercisable, derivative securities beneficially owned

4 terms

Stock Option (right to purchase) financial

"security_title: "Stock Option (right to purchase)""

Amended and Restated 2015 Stock Incentive Plan financial

"was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan"

vest and become exercisable financial

"Options to purchase 5,000 shares ... will vest and become exercisable"

derivative securities beneficially owned financial

"total_shares_following_transaction: "20000.0000""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Clarus Corp (CLAR) report for Susan Ottmann?

Clarus reported that director Susan Ottmann received a grant of stock options for 20,000 shares of common stock. These options were issued as compensation under the Amended and Restated 2015 Stock Incentive Plan and are held directly by her.

What is the exercise price of Susan Ottmann’s Clarus (CLAR) stock options?

The stock options granted to Susan Ottmann have an exercise price of $3.11 per share. This means she can purchase Clarus common stock at $3.11 per share once the options vest and are exercisable, subject to the plan’s terms.

How many Clarus (CLAR) shares are covered by Susan Ottmann’s new options?

The new option grant covers 20,000 shares of Clarus common stock. All 20,000 shares are tied to a single option award granted on May 28, 2026, with vesting spread across four future dates as detailed in the footnote.

When do Susan Ottmann’s Clarus (CLAR) stock options vest and become exercisable?

Ottmann’s options vest in four equal tranches of 5,000 shares each. They become exercisable on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, assuming continued service and satisfaction of plan conditions.

When do Susan Ottmann’s Clarus (CLAR) stock options expire?

The stock options granted to Susan Ottmann expire on May 28, 2036. After this expiration date, any unexercised portion of the 20,000-share option award will no longer be exercisable under the company’s Amended and Restated 2015 Stock Incentive Plan.

How many Clarus (CLAR) stock options does Susan Ottmann hold after this grant?

Following this transaction, Susan Ottmann holds 20,000 stock options directly. This total reflects the full amount of the new grant, as indicated by the reported figure for total derivative securities beneficially owned after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ottmann Susan

(Last) (First) (Middle)

C/O CLARUS CORPORATION

2084 EAST 3900 SOUTH

(Street)

SALT LAKE UTAH 84124

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clarus Corp [ CLAR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to purchase)	$3.11	05/28/2026		A		20,000		(1)	05/28/2036	Common Stock	20,000	$0	20,000	D

Explanation of Responses:

1. The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

	/s/ Susan Ottmann	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)